Quick Answer
Marker Therapeutics, Inc. reported Shares Outstanding of 16.70 million shares for fiscal year 2025.
Marker Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 16.70M | +56.1% |
| 2024 | 10.70M | +20.2% |
| 2023 | 8.90M | +6.0% |
| 2022 | 8.40M | +1.2% |
| 2021 | 8.30M | -83.6% |
| 2020 | 50.70M | +10.9% |
| 2019 | 45.70M | +0.7% |
| 2018 | 45.40M | +328.3% |
| 2017 | 10.60M | +26.2% |
| 2016 | 8.40M | +42.8% |
| 2015 | 5.88M | -71.0% |
| 2014 | 20.32M | +1286.3% |
| 2013 | 1.47M | -98.1% |
| 2012 | 76.40M | +46.7% |
| 2011 | 52.07M | +29.4% |
| 2010 | 40.26M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 16.70M | +87.6% | +47.8% |
| June 30, 2025 | 11.30M | +27.0% | +0.9% |
| March 31, 2025 | 11.20M | +25.8% | +4.7% |
| December 31, 2024 | 10.70M | +20.2% | +20.2% |
| September 30, 2024 | 8.90M | +1.1% | +0.0% |
| June 30, 2024 | 8.90M | +1.1% | +0.0% |
| March 31, 2024 | 8.90M | +1.1% | +0.0% |
| December 31, 2023 | 8.90M | +6.0% | +1.1% |
- Marker Therapeutics, Inc. showed an increase of +56.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Marker Therapeutics, Inc.’s shares outstanding has declined by 58.5% (from 40.26 million shares to 16.70 million shares).
- The most recent figure is from Marker Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: